Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

<p>Abstract</p> <p>Background</p> <p>Few data are available on compliance and safety of adjuvant chemotherapy when indicated in elderly breast cancer patients; CMF (cyclophosphamide, methotrexate, fluorouracil) can be reasonably considered the most widely accepted stand...

Full description

Bibliographic Details
Main Authors: Rinaldo Massimo, Capasso Immacolata, D'Aiuto Giuseppe, Rossi Emanuela, Nuzzo Francesco, Landi Gabriella, Labonia Vincenzo, Amabile Gerardo, Pacilio Carmen, Gravina Adriano, De Maio Ermelinda, Morrica Brunello, Elmo Massimo, Di Maio Massimo, Perrone Francesco, de Matteis Andrea
Format: Article
Language:English
Published: BMC 2005-03-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/5/30

Internet

http://www.biomedcentral.com/1471-2407/5/30

Similar Items